Sensitive HPV Genotyping Based on the Flow-Through Hybridization and Gene Chip

Table 3

Positive rates of different HPV genotypes in each group detected by HybriMax.

HPV type	Group no. of patients %							Normal
	Total	A	B	C	D	E	F
16	28.9	19.7	21.8	32.5	47.4	55.6	15.0	8.0
18	16.8	14.5	14.9	15.6	21.1	25.9	20.0	6.5
31	9.7	11.2	6.9	10.4	13.2	3.7	5.0	1.4
33	9.9	6.6	11.9	13.0	10.5	14.8	5.0	0.7
35	0.2	0.7	—	—	—	—	—	—
39	4.2	5.3	4.0	3.9	3.9	—	5.0	1.4
45	0.6	0.7	1.0	1.3	—	—	—	—
51	4.0	3.3	2.0	10.4	2.6	3.7	—	0.7
52	19.0	11.8	21.8	26.0	25.0	22.2	5.0	3.6
53	8.6	10.5	8.9	6.5	6.6	3.7	15.0	2.2
56	4.0	4.6	7.9	2.6	1.3	—	—	0.7
58	19.1	14.5	22.8	18.2	28.9	18.5	—	3.6
59	1.1	1.3	2.0	1.3	—	—	—	—
66	5.1	3.9	5.9	3.9	5.3	11.1	5.0	—
68	8.4	9.9	10.9	6.5	6.6	7.4	—	7.2
81	8.8	8.6	7.9	13.0	7.9	3.7	10.0	0.7
6	2.9	0.7	5.0	1.3	1.3	—	30.0	0.7
11	4.4	2.6	3.0	—	2.6	—	55.0	2.9
42	0.2	0.7	—	—	—	—	—	—
43	—	—	—	—	—	—	—	—
44	0.8	—	2.0	1.3	—	—	5.0	—

Group A: chronic cervicitis; group B: CIN I; group C: CIN II; group D: CIN III; group E: SCC; group F: condyloma acuminata.